97
Participants
Start Date
July 31, 2012
Primary Completion Date
August 8, 2016
Study Completion Date
October 27, 2016
Adalimumab (Humira)
Humira will be given at an initial dose of 80mg followed by 40 mg the second week, subsequent doses will be given at 40mg and follow FDA dosing schedule.
Placebo Injection
Placebo injection will be given according to the same dose and schedule as the active comparator.
NB-UVB phototherapy
Phototherapy will be given 3 times per week according to the Fitzpatrick scale for skin types.
Buffalo Medical Group, Buffalo
The University of Pennsylvania, Philadelphia
National Heart, Lung, and Blood Institute, Bethesda
Menter Dermatology Research Institute, Dallas
Center for Clinical Studies, Houston
The University of Colorado, Denver
University of Utah, Salt Lake City
University of California, Davis Health System, Sacramento
Oregon Health & Science University, Portland
University of Pennsylvania
OTHER